MAR-13593-87073
4 vaccinations
1 coded response
38 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 441 / OH
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Dose 1 — Pfizer-BioNTech
-
2021-03-27
Registered in v-safe
-
2021-03-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-03-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
-
2021-04-16
Dose 2 — Pfizer-BioNTech
- 2021-04-16
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-22
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-07-16
- 2021-10-15
-
2021-12-23
Dose 3 — Moderna
- 2022-04-16
- 2022-06-23
-
2022-10-03
Dose 4 — Moderna
-
2022-10-04
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fever · Headache, Joint pains · Be unable to work or attend schoolAdult check-in
-
2022-10-05
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fever · Muscle or body achesAdult check-in
- 2022-10-06
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-17
- 2022-10-26
- 2022-11-01
- 2022-11-07
- 2022-11-14
-
2023-01-02
Survey response — 3 months, dose 4MedDRA: Pityriasis rosea — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-02
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-03
Call successfulParticipant prefers to complete VAERS report online
- 2023-04-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-16 | Pfizer-BioNTech | |
| 3 | 2021-12-23 | Moderna | No |
| 4 | 2022-10-03 | Moderna | No |
Call center
1 call center case
1 successful
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pityriasis rosea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release